Beth P. Hecht

Beth P. Hecht serves as Senior Vice President, General Counsel, and Corporate Secretary of Xeris Pharmaceuticals. She has over 25 years of experience as a corporate executive in the life science industry, most recently serving as Managing Director and Chief Legal and Administrative Officer for Auven Therapeutics, global biotechnology, and a pharmaceutical private equity firm. Beth is currently a member of the Board of Directors of Iterum Therapeutics (Nasdaq: ITRM) and was previously on the Board of Directors of Neos Therapeutics, (acquired by Aytu BioPharma) where she chaired the Nominating and Governance Committee.

Ms. Hecht is a graduate of Amherst College and Harvard Law School and started her career as an attorney specializing in intellectual property and corporate transactions at Willkie Farr & Gallagher (NY) and then Kirkland & Ellis (NY). She has established and led legal, compliance, licensing, human resource, and security departments at companies including Durata Therapeutics, Sun Products, MedPointe Inc. (formerly known as Carter-Wallace Inc.), Warner Chilcott PLC, ChiRex Ltd., and Alpharma Inc.